Sundan A - Search Results

1

Myeloma-derived extracellular vesicles mediate HGF/c-Met signaling in osteoblast-like cells.

Strømme O, Psonka-Antonczyk KM, Stokke BT, Sundan A, Arum CJ, Brede G. Strømme O, et al. Among authors: sundan a. Exp Cell Res. 2019 Oct 1;383(1):111490. doi: 10.1016/j.yexcr.2019.07.003. Epub 2019 Jul 5. Exp Cell Res. 2019. PMID: 31283912

2

Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines.

Borset M, Lien E, Espevik T, Helseth E, Waage A, Sundan A. Borset M, et al. Among authors: sundan a. J Biol Chem. 1996 Oct 4;271(40):24655-61. doi: 10.1074/jbc.271.40.24655. J Biol Chem. 1996. PMID: 8798732 Free article.

3

Hepatocyte growth factor and its receptor c-met in multiple myeloma.

Börset M, Hjorth-Hansen H, Seidel C, Sundan A, Waage A. Börset M, et al. Among authors: sundan a. Blood. 1996 Nov 15;88(10):3998-4004. Blood. 1996. PMID: 8916966 Free article.

4

Role of hepatocyte growth factor and its receptor c-met in multiple myeloma.

Seidel C, Børset M, Hjorth-Hansen H, Sundan A, Waage A. Seidel C, et al. Among authors: sundan a. Med Oncol. 1998 Sep;15(3):145-53. doi: 10.1007/BF02821933. Med Oncol. 1998. PMID: 9819791 Review.

5

Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice.

Hjorth-Hansen H, Seifert MF, Börset M, Aarset H, Ostlie A, Sundan A, Waage A. Hjorth-Hansen H, et al. Among authors: sundan a. J Bone Miner Res. 1999 Feb;14(2):256-63. doi: 10.1359/jbmr.1999.14.2.256. J Bone Miner Res. 1999. PMID: 9933480 Free article.

6

The role of hepatocyte growth factor and its receptor c-Met in multiple myeloma and other blood malignancies.

Børset M, Seidel C, Hjorth-Hansen H, Waage A, Sundan A. Børset M, et al. Among authors: sundan a. Leuk Lymphoma. 1999 Jan;32(3-4):249-56. doi: 10.3109/10428199909167385. Leuk Lymphoma. 1999. PMID: 10037022 Review.

7

Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease.

Hjertner O, Torgersen ML, Seidel C, Hjorth-Hansen H, Waage A, Børset M, Sundan A. Hjertner O, et al. Among authors: sundan a. Blood. 1999 Dec 1;94(11):3883-8. Blood. 1999. PMID: 10572104 Free article.

8

High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity.

Seidel C, Børset M, Hjertner O, Cao D, Abildgaard N, Hjorth-Hansen H, Sanderson RD, Waage A, Sundan A. Seidel C, et al. Among authors: sundan a. Blood. 2000 Nov 1;96(9):3139-46. Blood. 2000. PMID: 11049995 Free article.

9

Interleukin-21 is a growth and survival factor for human myeloma cells.

Brenne AT, Ro TB, Waage A, Sundan A, Borset M, Hjorth-Hansen H. Brenne AT, et al. Among authors: sundan a. Blood. 2002 May 15;99(10):3756-62. doi: 10.1182/blood.v99.10.3756. Blood. 2002. PMID: 11986233 Free article.

10

Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells.

Ro TB, Holt RU, Brenne AT, Hjorth-Hansen H, Waage A, Hjertner O, Sundan A, Borset M. Ro TB, et al. Among authors: sundan a. Oncogene. 2004 Apr 15;23(17):3024-32. doi: 10.1038/sj.onc.1207386. Oncogene. 2004. PMID: 14691444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters